We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
BD said last week that it will acquire CareFusion for $12.2 billion as part of an ongoing shift from a product-focused company to a provider of “healthcare solutions,” particularly in medication management and patient safety. Read More
The FDA is asking a federal court to permanently enjoin Pharmaceutical Innovations from manufacturing, selling and distributing ultrasound devices and gels. Read More